Here, we discuss some reasons why buying ATRA stock now may turn out to be a prudent move.

Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This...

One […]

Rising expenses are likely to hurt ZTO's bottom line.

ABM's multi-year initiative ELEVATE is driving shareholder value and strengthening its industry leadership position.

Nomura (NMR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend...

The VRSK stock benefits from transitioning to a subscription-based model from a transaction business model.

The IT stock is benefiting from a diverse array of products and services that cater to different customer needs.

THERE were mixed opinions among several people Newsday interviewed in Port of Spain hours after the Prime Minister announced his intention to resign...

VERX's strong portfolio, increasing customer base and product integrations make it a compelling investment option at present.